RBC Capital Reiterates Outperform Rating on Karyopharm Therapeutics (KPTI)
Go back to RBC Capital Reiterates Outperform Rating on Karyopharm Therapeutics (KPTI)| KARYOPHARM THERAP (NASDAQ: KPTI) | Delayed: 2.02 +0.03 (1.51%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.99 | 52 Week High | $19.41 | |||
| Open | $1.97 | 52 Week Low | $4.83 | |||
| Day High | $2.06 | P/E | N/A | |||
| Day Low | $1.97 | EPS | $-2.74 | |||
| Volume | 884,425 | |||||
